SLRN
ACELYRIN, INC. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website acelyrin.com
- Employees(FY) 108
- ISIN US00445A1007
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: SLRN
Overview:
SLRN is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $812,784,741. In this report, we will conduct a comprehensive analysis of SLRN's financial health, valuation, earnings and revenue growth, profitability, operating margin, operating cash flow, and ...
Technical Analysis of SLRN 2024-05-31
Overview:
In analyzing the technical indicators for SLRN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-28 19:00
- 2024-05-14 23:54
SLRN Stock Earnings: Acelyrin Beats EPS for Q1 2024(Investorplace)
- 2024-05-09 08:01
- 2024-05-09 08:00
ACELYRIN, INC. Announces Leadership Transition(GlobeNewswire)
- 2024-05-08 20:01
- 2024-05-08 20:00
ACELYRIN, INC. Announces Leadership Transition(Globenewswire)
- 2024-04-29 16:05
- 2024-04-29 04:05
- 2024-04-12 09:05
Acelyrin Insiders Placed Bullish Bets Worth US$2.65m(Simply Wall St.)
- 2024-03-28 16:05
- 2024-03-28 10:53
SLRN Stock Earnings: Acelyrin Beats EPS for Q4 2023(Investorplace)
- 2024-03-28 04:05
- 2024-03-27 16:01
- 2024-03-27 04:01
- 2024-03-20 23:12
- 2024-03-20 07:00
- 2024-03-20 00:39
- 2024-03-19 19:00
- 2024-03-11 08:02
- 2024-03-11 08:00
- 2024-03-10 22:04
- 2024-03-10 20:02
- 2024-03-10 20:00
- 2024-02-15 16:05
- 2024-02-15 03:05
- 2024-01-09 22:30
- 2024-01-03 20:56
- 2023-12-31 20:35
- 2023-12-26 21:45
- 2023-12-20 16:30
ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors(GlobeNewswire)